tbuckley/cabot-search huggingface dataset:
Medicare Report
Authors: Tracy Hampton
Journal: JAMA (2011)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The necessary length of hospital stay for chronic pulmonary disease
Authors: A. I. Mushlin
Journal: JAMA (1991)

<h3>Objective.</h3> —To determine the necessary length of stay for patients admitted to the hospital with an exacerbation of chronic pulmonary disease and to compare this with the length of stay assigned by the diagnosis related group system. <h3>Design.</h3> —A cohort of patients were followed up prospectively after hospital admission to determine when complications, critical incidents, and the need for monitoring occurred. The medically derived necessary lengths of stay were statistically compared with the lengths of stay assigned by the diagnosis related group. Clinical factors were used to predict long vs short necessary lengths of stay. <h3>Setting.</h3> —Two acute care hospitals: one was the principal and the other a major community teaching hospital. <h3>Patients.</h3> —A consecutive sample of 83 patients who were 45 years of age or older and who required admission for treatment of chronic pulmonary disease. <h3>Main Outcome Measures.</h3> —The occurrence and time of complications, critical interventions, and monitoring. <h3>Results.</h3> —After 6 days in the hospital, 90% of patients were free of complications or the need for monitoring. However, 16 days elapsed before 90% of patients had been discharged from the hospital. The length of stay that was considered necessary for care averaged 6.9 days; the actual mean length of stay was 8.7 days. The correlation between each patient's ideal length of stay and the length of stay assigned by the diagnosis related group was low and was not statistically significant. Three clinical variables at the time of admission (high Pco<sub>2</sub>levels, symptoms that were present for more than 1 day, and antibiotic treatment) were associated with the need for longer hospital stays. <h3>Conclusions.</h3> —The medically required length of stay for patients with an exacerbation of chronic pulmonary disease was between 6 and 7 days, on average. This length of stay, which was based on clinical events, differs from the length of stay that was calculated as a statistical norm by the diagnosis related group system. Clinical characteristics may help to identify patients who require a longer length of stay. (<i>JAMA</i>. 1991;266:80-83)
Editors, Contents, Cover details
Authors: Rebecca Schwarzlose, Katja Brose, Rolf Van Der Sanden, Patrick Scheffmann, Ria Otten, R Adolphs, R Baillargeon, N Chater, P Dayan, S Dehaene, D Dennett, Y Dudai, A Engel, M Farah, A Friederici, O Hikosaka, R Jackendoff, P Johnson-Laird, N Kanwisher, M Kutas, N Logothetis, J Mcclelland, E Miller, R Poldrack, M Raichle, T Robbins, A Wagner, V Walsh, Sandra Waxman, Giovanni Pezzulo, Matthijs Van Der Meer, Mark Sheskin, Coralie Chevallier, Stéphane Lambert, Nicolas Baumard, Barbara Finlay, Supriya Syal, Sophie Scott, Nadine Lavan, Sinead Chen, Carolyn Mcgettigan, Marc Zirnsak, Tirin Moore, Jocelyn Breton, Edwin Robertson, Scott Moeller, Rita Goldstein
Journal: Trends in Cognitive Sciences (2014)
Anthracycline antibiotics and the heart
Authors: S. Vaisrub
Journal: JAMA (1977)

Whenever we prescribe antimicrobial antibiotic, our attention is usually focused on the kidney more than any other organ because of its exposure to high concentrations of the drug by glomerular filtration and tubular reabsorption. Sometimes, as with antibiotics of the tetracycline group, we worry about the gastrointestinal tract, which may become vulnerable to injury by commensals. Frequently, we may be concerned with injury to the blood cells or the liver. Rarely, if ever, do we think of the heart as a target of antibiotic toxicity. With the advent of antitumor antibiotics of the anthracycline group, the heart lost its privileged position vis-à-vis other organs. It, too, became vulnerable. An increasing number of reports have attested to this vulnerability since Tan et al<sup>1</sup>reported lethal cardiotoxicity in seven children, and Ainger et al<sup>2</sup>described a similar fatal outcome in two adults, in whom electronmicroscopic study of the myocardium demonstrated
Genetic Alterations in Carcinogenesis and Chemoprevention
Authors: Miriam P. Rosin
Journal: Environmental Health Perspectives (1993)

Laboratory and clinical studies suggest that genetic change is intrinsically involved in the development of cancer and that this change occurs in humans throughout carcinogenesis, in both early and late stages.Therefore, the quantification of the level of genetic change in human epithelial tissues may serve as a marker for cancer risk.The micronucleus test has been used to quantify the level of site-specific chromosomal breakage occurring in epithelial tissues of individuals at elevated risk for cancer.These studies include individuals exposed to carcinogens, patients who have chromosome-breakage syndromes, and individuals with premalignant lesions.As a counterpart to this approach, the assay has been used to study the suppression of this breakage with chemopreventive agents, some of which occur naturally in the diet.These agents include P-carotene, retinyl palmitate, 13-cis-retinoic acid, riboflavin, canthaxanthin, and folic acid.Not all of these agents were effective.The success of the treatment depended on both the agent being used and the population being studied.The results of these studies suggest that successful intervention with chemopreventive agents will depend on tailoring treatment regimens to specific populations.The micronucleus test can be used along with other biological end points to obtain an early indication of the efficacy of chemopreventive agents in altering biological changes associated with carcinogenesis in tissues of high-risk individuals.
Antithyroid-thyroid therapy for thyrotoxicosis
Authors: H. A. Selenkow
Journal: JAMA (1970)

<h3>To the Editor.—</h3> In a recent THERAPEUTIC GRAND ROUNDS (213:1652, 1970), Dr. William Green, the discussant in an exercise entitled "Management of Juvenile Hyperthyroidism," alludes to combined use of an antithyroid drug and thyroid replacement for therapy for this disorder. Dr. Green cites the Billings' Lecture delivered by Dr. John Eager Howard (<b>202</b>:706-709, 1967) as a supporting reference. With due deference to Dr. Howard's serendipitous discovery of antithyroid-thyroid therapy for thyrotoxicosis, scientific credits for introducing this approach to therapy should be clarified. Fraser and Wilkinson (<i>Brit Med J</i><b>1</b>:481-484, 1953) were, to my knowledge, the first to publish objective clinical data on the use of thyroid hormones together with antithyroid drugs. These investigators surely deserve the primary citation. Their report reviewed animal research supporting the physiologic basis for this usage and referred to other investigators who had previously recommended combined therapy. Their findings were substantiated later by Bergfelt
Cisplatin overdosage.
Authors: I M Pike, M H Arbus
Journal: Journal of Clinical Oncology (1992)

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1992.10.9.1503 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 1517794 Cisplatin overdosage. I M PikexI M PikeSearch for articles by this author , M H ArbusxM H ArbusSearch for articles by this author https://doi.org/10.1200/JCO.1992.10.9.1503 PDF "Cisplatin overdosage.." Journal of Clinical Oncology, 10(9), pp. 1503–1504© 1992 by American Society of Clinical Oncology
REPORT ON ABDOMINAL AND PELVIC SURGERY.Report of the Chairman of the Committee on Abdominal and Pelvic Surgery, read before the Kentucky State Medical Society, May (6, 1892.
Authors: WILLIAM H. WATHEN
Journal: JAMA (1892)

REPORT OF THIRTY-ONE SUCCESSFUL LAPAROTOMIES. (Concluded from page 696.) In reporting the following cases I will omit many of the minor details. All of these operations except one were on intelligent private patients, and most of them at St. Joseph's Infirmary; they were seen by some of our most reputable physicians, and my chief assistant was usually either Dr. J. M. Holloway or Dr. F. W. Samuels, and the aæsthetizer Dr. Henry Orendorf. Case 1.—Mrs. W., from New Haven, Ky.; aged 32; married fifteen years; has never been pregnant; was referred to me in the fall of 1889. A few months after marriage she had pelvic peritonitis and has since been an invalid, frequently suffering intense pain in the uterus or its adnexa, especially severe at the menstrual period. She has been treated by many physicians with but little temporary relief. The body of the uterus is pressed against the
Does age count in pancreatic resection? An Irish experience.
Authors: Louise Catherine Connell, Erica Mulvihill, Margaret O'Keeffe, Seamus O'Reilly, Justin Geoghegan, Criostoir O'Suilleabhain, Derek Gerard Power
Journal: Journal of Clinical Oncology (2012)

348 Background: Radical resection offers the only potential cure in pancreas cancer. The majority of patients (pts) are &gt;65 years(yrs) at presentation. Age alone is often a key factor in deciding to resect. The elderly represent 11.5% of the population of Ireland, with an anticipated growth of 26% in the over-65 age group by the end of 2011. Appropriate treatment for elderly potential candidates for pancreatic resection has become increasingly important. We assessed our national experience of pancreatic resection for elderly pts. Methods: Prospectively maintained institutional databases were retrospectively reviewed for all pts undergoing pancreatic resection from 2006 to 2011, in the 2 specialised pancreas cancer centres in Ireland. Demographic, laboratory, treatment and outcome data were obtained and analysed. Results: In a single institution,of the 69 pts who had surgery for pancreas neoplasm, 19 (28%) pts were ≥ 70 yrs. Surgical procedures included pancreaticoduodenectomy (n=16, 84%) and double biliary bypass (n=3,16%). Pathologies included adenocarcinoma (AC) (n=16,84%) and NET (neuroendocrine tumour)/IPMN(intraductal papillary mucinous neoplasms) (n=3, 16%). Number of R0 resections was 15 (15/16,94%). Median baseline ECOG was 1 (range, 0-2).There was no perioperative mortality. Median length of hospital stay was 13 days (range,9-50). Thirteen pts who underwent pancreatico-duodenectomy for AC (81%) received adjuvant chemotherapy (with expected toxicities). Ten pts, after pancreatico-duodenectomy and adjuvant therapy had at least 2 yrs follow-up with median overall survival of 21.5 mths (range,12-44). A further 3 pts aged ≥ 80 yrs underwent pancreaticoduodenectomy followed by adjuvant chemotherapy in the past 12 mths, with no peri-operative complications or significant acute chemotherapy-related toxicities. The data set from the second specialised pancreas cancer centre, with similar survival outcomes, is currently being added to provide overall national results. Conclusions: Age alone should not be a contraindication to pancreatic resection in elderly pts with pancreas cancer. This group can undergo pancreatic resection, with acceptable post-operative morbidity, mortality and overall outcome as evidenced by our national experience.
JAMA Reference Directories
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
INORGANIC CONSTITUENTS OF TUMORS.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reference Directories
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAMA Internal Medicine
Authors: Phil Fontanarosa, Annette Flanagin, Brenda Gregoline, Lauren Fischer, John Mcfadden, Karen Boyd, Rochelle Lodder, Sam Wilder, Diane Cannon, Connie Manno, Fred Marshall, Catherine Copyreaders, Stephanie Alden, Jan Beckmeyer, Mary Clavey, Paula Coerver-Connolly, Laura Glitman, Kenneth King, Donna Lane, Caroline Thordsen, Wanda Assistant, Larry Bryant, Monica Mungle, Elaine Williams, Kathryn Brokke, Fanny Brown, Paul Frank, Lenette Gardner-Gullens, Peter Kim, Rachell Lozano, Michaela Mark, Elizabeth Scientifi, Michael Berkwits, Michelle Kurzynski, Eric Butkus, Will English, Mustafa Ishaq, Daniel Morrow, Reuben Rios, Ronna Henry, Joshua Bird, Karen Bucher, Samantha Welker, David Song, Deputy Livingston, Thomas Cole, Marla Hall, Deanna Willis, Yolanda Davis, Joseph Thornton, Preeti Malani, Deanna Bellandi, Jim Periodical, Thomas Easley, Brian Shields, Monica Smith, Jeff Ery, J Bonistalli, Kathy Russell, Mirna Monal, Stacey Mchugh, Tim Melroy, Marketing Thornbury, Tricia Castellano Classifi, Thalia Moss, Mike Harvey, Susan Henning, Saskia Bolore, Gretchen Linder, Brian Mccartney, David Baum, Rebecca Haas, Christine Hearne, Natasha Nekola, Ron Marketing, Paul Gee, Matt Herron, Elizabeth Solaro, Geoff Rey, Rick Bell, Lindsay Dawson, Craig Mccaff Rey, Michael Mcgraw, Romando Rossini, Stacy Staff, Millette Jackson-Bates, Karen Adams-Taylor, Karl Elvin, Jaye Mize, Sean O'donnell, Sue Managers, David Antos, Chris Borden, Debbie Camp, Lydia Cruz, Scott Curl, Diane Darnell, Colleen Kelly, Chris Meyer, Annemarie Neff, J Neff, Sean Ohlson, Phil O'leary, Bill Pedone, Susan Price, Denise Steinhauser, Joe Advertising, Production Services, Kim Boler, Rhonda Brown, Timothy Burke, Daniel Degroot, Jordynn Farrar, Euwanaha Joiner-Smith, Cindy Rendlen, Ellen Yoshihara, Circulation Services, Julie Burton, Dexter Golden, Erin Hinchcliff, Noemi Rivera, Geneine Van, Someren Composition, New Media, Gail Barrett, Regina Brownlee, Amanda Camino, Brenda Chandler-Grayer, Emily Dunn, Amy Evers, Teri Hutchison, Mary Kuranda, Joshua Lampinen, Nathan Mitre, Patricia Panek, La Son, Diggs Sledge, George Thomson Graphics, Joe Amft, Maria Duda, Fred Furtner, Carolyn Hall, Maria Kowalkowski, Proofreading Carol, Joy Farrell, Daniel James, Judith Literskis, Teresa Omiotek, James Madara, Bernard Hengesbaugh, Zachary Goldberger, Nora Goldschlager, San Francisco, Elsayed Soliman, Carolina Cme, Jeff Rey Tabas, Fiona Clement, Rebecca Larson, Deborah Grady, Howard Bauchner, Rita Redberg, Rosemary Gibson, Shannon Brownlee, Tanner Caverly, Ann Arbor, Brandon Combs, Christopher Moriates, Neel Shah, Robert Steinbrook, New Haven, James Colbert, David Brown, St Louis, Lara Goitein, Santa Fe, New Mexico, Chi-Yuan Hsu, Grace Lin, Mary Mcdermott, C Noel, Bairey Merz, Los Angeles, Samia California, Judith Mora, Kathryn Prochaska, Mary Rexrode, New Tinetti, Nicolas Rodondi, Iona Heath, Mitchell Katz, Patrick California, John Boscardin, John Neuhaus, Kenneth Covinsky, Joseph Ross, Blake Charlton, Rachel Stern, Charlotte Dudley, Kate Denevan
Journal: JAMA Internal Medicine (2015)
A Bibliography of Eugenics.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Right Atrial Myxoma Successfully Removed
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal